REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 120 filers reported holding REVOLUTION MEDICINES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,116,054 | +5.7% | 76,447 | +2.1% | 0.00% | 0.0% |
| Q2 2023 | $2,002,827 | +22.0% | 74,872 | -1.2% | 0.00% | 0.0% |
| Q1 2023 | $1,641,460 | +9.8% | 75,783 | +20.8% | 0.00% | 0.0% |
| Q4 2022 | $1,494,275 | +43.0% | 62,732 | +18.4% | 0.00% | – |
| Q3 2022 | $1,045,000 | +21.1% | 52,999 | +19.6% | 0.00% | – |
| Q2 2022 | $863,000 | -22.9% | 44,308 | +1.0% | 0.00% | – |
| Q1 2022 | $1,119,000 | +3.2% | 43,859 | +1.8% | 0.00% | – |
| Q4 2021 | $1,084,000 | -8.5% | 43,071 | 0.0% | 0.00% | – |
| Q3 2021 | $1,185,000 | +10.5% | 43,071 | +27.4% | 0.00% | – |
| Q2 2021 | $1,072,000 | -3.9% | 33,799 | +39.0% | 0.00% | – |
| Q1 2021 | $1,116,000 | +441.7% | 24,321 | +367.4% | 0.00% | – |
| Q4 2020 | $206,000 | 0.0% | 5,204 | -12.3% | 0.00% | – |
| Q3 2020 | $206,000 | +119.1% | 5,932 | +100.3% | 0.00% | – |
| Q2 2020 | $94,000 | -79.2% | 2,961 | -85.7% | 0.00% | – |
| Q1 2020 | $453,000 | – | 20,755 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |